October 29, 2019
Prothena investors urged a New York federal court Monday to grant their attorneys at Labaton Sucharow LLP and Levi & Korsinsky LLP $4.7 million in fees and give the final go-ahead to a $15.75 million deal with the biotechnology company, resolving securities fraud claims over a clinical trial.
August 27, 2019
Prothena investors have negotiated a $15.75 million settlement with the neuroscience research and development company, which would end claims that it hid salient details of a clinical trial for a new drug and hurt shareholders when revelations about the trial made its stock price fall by nearly 70%.
September 18, 2018
Labaton Sucharow LLP and Levi & Korsinsky LLP threw their hats in the ring to be co-lead counsel in a proposed securities class action alleging Prothena cherry-picked drug trial results and lost investors more than $2 million, according to a Monday filing in New York federal court.